Completed PHASE1 INTERVENTIONAL 2-arm NCT03657537

Effects of Ketone Bodies on Cognition in Type 2 Diabetes (KETOCOGNITION)

KETOCOGNITION - Effects of Ketone Bodies on Cognition in Type 2 Diabetes

Sponsor: Bispebjerg Hospital

Conditions Cognitive Change Ketonemia Type2 Diabetes

Interventions Ketone infusion Saline infusion

Updated 6 times since 2018 Last updated: Feb 19, 2019 Started: Sep 17, 2018 Primary completion: Feb 14, 2019 Completion: Feb 14, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cognitive Change and Ketonemia and is currently completed. Bispebjerg Hospital leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Mar 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Feb 2019 — Mar 2019 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Oct 2018 — Feb 2019 [monthly]

Recruiting PHASE1

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bispebjerg Hospital
Psychiatric Centre Rigshospitalet

Data source: Bispebjerg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark